BerGenBio Balance Sheet Health
Financial Health criteria checks 5/6
BerGenBio has a total shareholder equity of NOK175.3M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK218.5M and NOK43.2M respectively.
Key information
0%
Debt to equity ratio
NOK 0
Debt
| Interest coverage ratio | n/a |
| Cash | NOK 200.12m |
| Equity | NOK 175.26m |
| Total liabilities | NOK 43.21m |
| Total assets | NOK 218.47m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BGBIOO's short term assets (NOK218.3M) exceed its short term liabilities (NOK43.2M).
Long Term Liabilities: BGBIOO has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BGBIOO is debt free.
Reducing Debt: BGBIOO has no debt compared to 5 years ago when its debt to equity ratio was 0.08%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BGBIOO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: BGBIOO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 6.1% each year